Medical Device News Magazine
HomeMARKET REPORTS

MARKET REPORTS

Europe $3.53 Bn Sleep Apnea Devices Markets 2024-2032 by Types, Therapeutic Devices, Diagnostic Devices, End User, and Company Analysis

Europe sleep apnea devices market turned into US$ 1.81 billion in 2023 and is expected to reach US$ 3.53 billion by 2032, with a CAGR of 7.70% from 2024 to 2032.

Diabetes Care Devices Market Forecast to 2028

The "Diabetes Care Devices, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Venous Thromboembolism Treatment Market to be Worth $4.40 Billion by 2030

According to a new market research report titled 'Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) – Global Forecast to 2030,' published by Meticulous Research®, the venous thromboembolism treatment market is projected to reach $4.40 billion by 2030, at a CAGR of 7.2% from 2023 to 2030.

Dental 3D Printing Materials Market to be Worth $5.4 Billion by 2031

According to a new market research report, 'Dental 3D Printing Materials Market Size, Share, Forecast, & Trends Analysis by Type [Polymers (Resins, Thermoplastics), Composites, Ceramics (Zirconia, Alumina], Application (Crowns, Bridges, Dentures, Surgical Guides, Implants)– Global Forecast to 2031,' published by Meticulous Research®, the dental 3D printing materials market is projected to reach USD 5.4 billion by 2031, at a CAGR of 27.3% from 2024 to 2031.

Surgical Suction Instruments Market to Hit USD 503 Million by 2029, Driven by 6.1% CAGR

The global surgical suction instruments market is projected to reach USD 503 million by 2029, growing at a CAGR of 6.1% from USD 375 million in 2024, driven by increasing adoption of minimally invasive surgery and rising prevalence of chronic diseases.

Flow Cytometry Market Surges to $10.3 Billion by 2032, Driven by 9.2% CAGR Growth

The global flow cytometry market, valued at $5.1 billion in 2024, is primed for substantial growth, projected to achieve a remarkable compound annual growth rate (CAGR) of 9.2% over the forecast period, ultimately reaching $10.3 billion by 2032.

Medical Laser Market to Be Worth $17.3 Billion by 2031

According to a new market research report titled, 'Medical Laser Market by Type (Device Type (Solid-state Lasers, Gas Lasers, Dye Lasers, Diode Lasers), Fiber Type (Disposable Laser Fibers, Reusable Laser Fibers)), Application (Device, Fiber), and Geography—Global Forecast to 2031,' the medical laser market is projected to reach $17.3 billion by 2031, at a CAGR of 17.6% from 2024–2031.

Ambulatory EHR Market to be Worth $7.84 billion by 2031 – Exclusive Report

Ambulatory electronic health record (EHR) software is designed for outpatient care settings, enabling medical professionals to access a patient's complete medical history stored in an electronic format.

Global Carotid Artery Stent Market to Grow Substantially at a CAGR of ~3% by 2030

As per DelveInsight estimates, North America is anticipated to dominate the global carotid artery stent market during the forecast period.

AI Based Wound Care Software Market to Record an Exponential CAGR by 2031 – Exclusive Report by InsightAce Analytic

The AI Based Wound Care Software Market is estimated to exhibit a CAGR of 7.1% during the forecast period.
spot_imgspot_img

Recent News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”